by Fluoroscopy devices aid in visualization and imaging of internal organs, blood vessels and bones in real-time using X-ray radiation. Devices are used in diagnostic and interventional imaging procedures such as angioplasty and stent placements.
The global Fluoroscopy Devices Market is estimated to be valued at US$ 4720.31 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Chronic diseases such as diabetes, cancer and cardiovascular diseases require frequent diagnostic and interventional imaging using fluoroscopy devices. Advanced fluoroscopy devices offer high resolution imaging for improved visualization during complex surgeries and interventions for treatment of chronic conditions. Growing geriatric population also prone to chronic diseases will further drive the need for such devices during the forecast period.
SWOT Analysis
Strength: Fluoroscopy devices offer real-time imaging which helps physicians to efficiently diagnose and guide minimally invasive procedures. This improves clinical outcomes.
Weakness: Heavy radiation exposure during fluoroscopy raises risk of radiation-induced diseases like cancer over repeated and prolonged use. Devices also involve high maintenance and procurement costs.
Opportunity: Growing geriatric population and rising prevalence of chronic diseases is expanding the patient pool requiring image-guided procedures. This is creating opportunities for fluoroscopy devices market.
Threats: Strict regulations pertaining to radiation safety pose compliance challenges. Emergence of alternative non-ionizing imaging modalities also threatens market growth to some extent.
Key Takeaways
The Global Fluoroscopy Devices Market Demand is expected to witness high growth over the forecast period of 2023 to 2030. Regional analysis comprises- North America dominates currently due to developed healthcare infrastructure and rising incidence of chronic disorders in the region. Asia Pacific is anticipated to grow at fastest CAGR driven by increasing healthcare spending, large patient population and growing medical tourism.
Key players operating in the fluoroscopy devices market are Hologic Inc., Siemens Healthcare GmbH, Shimadzu Medical, Koninklijke Philips NV, FUJIFILM Holdings Corporation, Carestream Health, Canon Medical Systems Corporation, General Electric Company (GE Healthcare), and ATON GmbH (Ziehm Imaging Inc. and OrthoScan, Inc.). Growth strategies adopted by major players include new product launches, mergers & acquisitions and geographic expansions to strengthen market position.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc.
